These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26724896)

  • 21. Functional outcomes in schizophrenia: understanding the competence-performance discrepancy.
    Gupta M; Bassett E; Iftene F; Bowie CR
    J Psychiatr Res; 2012 Feb; 46(2):205-11. PubMed ID: 21944429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
    Harvey PD; Howanitz E; Parrella M; White L; Davidson M; Mohs RC; Hoblyn J; Davis KL
    Am J Psychiatry; 1998 Aug; 155(8):1080-6. PubMed ID: 9699697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.
    Cruz BF; Resende CB; Carvalhaes CF; Cardoso CS; Teixeira AL; Keefe RS; Rocha FL; Salgado JV
    Braz J Psychiatry; 2016; 38(3):216-21. PubMed ID: 27304257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.
    Kern RS; Nuechterlein KH; Green MF; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Mintz J; Seidman LJ; Stover E; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):214-20. PubMed ID: 18172018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Linke M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Green MF; Wichniak A
    Psychiatr Q; 2015 Sep; 86(3):435-47. PubMed ID: 25601030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.
    Javitt DC; Buchanan RW; Keefe RS; Kern R; McMahon RP; Green MF; Lieberman J; Goff DC; Csernansky JG; McEvoy JP; Jarskog F; Seidman LJ; Gold JM; Kimhy D; Nolan KS; Barch DS; Ball MP; Robinson J; Marder SR
    Schizophr Res; 2012 Apr; 136(1-3):25-31. PubMed ID: 22169248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
    Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
    Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
    Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
    Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China.
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2015 Dec; 169(1-3):109-115. PubMed ID: 26441005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.
    Bowie CR; Reichenberg A; Patterson TL; Heaton RK; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):418-25. PubMed ID: 16513862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compensatory cognitive training for people with first-episode schizophrenia: results from a pilot randomized controlled trial.
    Mendella PD; Burton CZ; Tasca GA; Roy P; St Louis L; Twamley EW
    Schizophr Res; 2015 Mar; 162(1-3):108-11. PubMed ID: 25631454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Functional outcome in schizophrenia: relation to the MATRICS consensus cognitive battery].
    Sumiyoshi C
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):251-7. PubMed ID: 22256615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological and functional correlates of clock-drawing test in elderly institutionalized patients with schizophrenia.
    Okamura A; Kitabayashi Y; Kohigashi M; Shibata K; Ishida T; Narumoto J; Morioka C; Kitabayashi M; Kashima A; Tani N; Nakaaki S; Mimura M; Fukui K
    Psychogeriatrics; 2012 Dec; 12(4):242-7. PubMed ID: 23279146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span.
    Khan WU; Ghazala Z; Brooks HJ; Subramaniam P; Mulsant BH; Kumar S; Voineskos AN; Blumberger DM; Kern RS; Rajji TK
    Schizophr Bull; 2021 Jan; 47(1):249-257. PubMed ID: 32619225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?
    Medalia A; Thysen J; Freilich B
    Schizophr Res; 2008 Oct; 105(1-3):156-64. PubMed ID: 18718740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.